| Similar Articles |
|---|
 |
Mother Jones
February 2001
Evelyn Nieves |
Half an Ounce of Healing The desperately ill members of a Santa Cruz marijuana club aren't growing pot to get high or make money. They just want to find some relief...   |
Reason
August 2002
Brian Doherty |
Following the Scrip Medical privacy in Florida: The Florida legislature has declined to go along with Gov. Jeb Bush's attempt to turn a family problem into a problem for the whole state. |
The Motley Fool
July 30, 2010
Brian Orelli |
A Faster Pathway to Drug Approvals A thinktank called the Pacific Research Institute has proposed letting drugs approved by the European Medicines Authority onto the market in the U.S. before the Food and Drug Administration has approved the drugs. |
Salon.com
August 31, 2000
David Tuller |
Striking down medical marijuana San Francisco's pro-pot district attorney discusses the long-term implications of the Supreme Court's ruling. |
Reason
September 2005
Jacob Sullum |
Data: Pot Bust If you have any lingering doubts about the political establishment's hypocrisy when it comes to drugs, consider this: Marijuana arrests reached an all-time high during the administration of the first acknowledged pot smoker to occupy the White House. |
The Motley Fool
July 12, 2010
Ryan McBride |
Synta Pharma CEO Trumpets New Top Cancer Drug Synta Pharmaceuticals has been climbing back from one of the Boston area's highest-profile clinical trial failures of 2009. |
Reason
February 2007
Greg Beato |
Pot Clubs in Peril Are San Francisco zoning boards a bigger threat to medical marijuana than the DEA? |
Reason
April 2002
Jacob Sullum |
Pot Stops In the United States, it's clearly not true that no one gets arrested for smoking pot anymore. But it looks like that will soon be the case in Britain, home of Europe's harshest drug laws... |
The Motley Fool
June 6, 2011
Luke Timmerman |
Exelixis Zeroes In on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients Is Exelixis' risky bet about to pay off? |
The Motley Fool
April 7, 2011
Brian Orelli |
Drug Approved! But Where's the Name? AstraZeneca prepares to cash in on a minuscule market. |
The Motley Fool
July 21, 2010
Brian Orelli |
Biogen Looks Good Now, but What About Tomorrow? Biogen Idec saw revenue increase 11% and adjusted earnings per share jump almost 75%, which is all well and good, but the longer-term prospects for the company aren't nearly as impressive. |
The Motley Fool
September 17, 2010
Luke Timmerman |
Cell Therapeutics OK'd to Sell Shares to Stay Alive Is the company being straight with shareholders? |
The Motley Fool
March 4, 2010
Brian Orelli |
A Painless Drug Deal Bristol-Myers licenses pain drug from Allergan. |
Reason
March 2002
Sara Rimensnyder |
One Toke over the Line In effect, the nation's highest court decided that state laws legalizing cannabis for medical use weren't worth a dime bag... |
The Motley Fool
January 25, 2011
Brian Orelli |
2 Keys to Amgen's Continued Success Prolia and Xgeva have to perform. |
BusinessWeek
July 15, 2010
Palmeri & Marois |
The Latest Fiscal Buzz? Medical Marijuana Cities are taxing marijuana dispensaries to trim budget deficits. |
The Motley Fool
October 8, 2010
Luke Timmerman |
Onyx Delays Cancer Drug Application As FDA Asks for More Data Shares fell about 7% in after-hours trading Thursday evening. |
AskMen.com
June 29, 2003
Bernie Alexander |
Worldwide Marijuana Sanctions This article explores the way the justice systems of different countries, such as the Netherlands, Mexico and Thailand, deal with crimes involving marijuana |
Salon.com
January 5, 2001
Daniel Forbes |
New Mexico thumbs its nose at the war on drugs A panel convened by Gov. Gary Johnson calls for the legalization of marijuana and a shift in focus from penal measures to treatment for drug offenders... |
Reason
November 2007
Jacob Sullum |
Spliff Split Candidates on marijuana: The U.S. House of Representatives once again rejected a measure aimed at stopping the DEA's interference with the therapeutic use of cannabis in the 12 states where it's legal. |
The Motley Fool
August 18, 2010
Brian Orelli |
No Pain Here as Jazz Shares Rocket Investors are all jazzed up about Jazz Pharmaceuticals |
The Motley Fool
March 8, 2010
Brian Orelli |
Really? A 59% Share Price Jump for That? Justified or not, InterMune skyrockets ahead of an FDA panel meeting. |
Pharmaceutical Executive
April 1, 2011 |
Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help. |
The Motley Fool
January 8, 2010
Brian Orelli |
Pfizer's Having a Garage Sale Rather than sending its unwanted drugs to the trash bin, the giant drugmaker is striking deals with its comrades to take them off its hands. |
Salon.com
March 27, 2000
Fiona Morgan |
"Humanitarian cease-fire" in the war on drugs A Maine sheriff wants the Legislature to let authorities dole out confiscated pot to people who need medicinal marijuana. |
The Motley Fool
December 31, 2010
Brian Orelli |
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. |
Salon.com
May 15, 2001
Daniel Forbes |
Let them eat chemo Will the Supreme Court's ostrich-like ruling shut down the medical marijuana movement? |
The Motley Fool
February 16, 2010
Brian Orelli |
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. |
Salon.com
March 29, 2001
Daryl Lindsey |
Up in smoke The U.S. Supreme Court seems poised to close down California's pot buyer's clubs... |
The Motley Fool
June 6, 2011
Brian Orelli |
Big Pharma Tackles Lung Cancer; Biotech Helping, Too A big underserved market. |
BusinessWeek
May 27, 2010
Pettypiece & Gibson |
Training the Immune System to Fight Cancer Bristol-Myers' new melanoma drug may be a "game changer." |
Reason
February 2009
Jacob Sullum |
Pot Holders Rejoice Drug decriminalization -- in November, Massachusetts voters approved Question 2, a ballot initiative that eliminates criminal penalties for possessing up to an ounce of marijuana |
Reason
March 2003
Jacob Sullum |
High Road Is marijuana a "gateway"? |
The Motley Fool
July 30, 2010
Brian Orelli |
3 Development-Stage Drugmakers Worth Watching A basket of potential drugs in just one company. |
The Motley Fool
August 10, 2010
Brian Orelli |
When the Disease Matters Most in Drug Approval Glaxo's and Valeant's Potiga will go before an FDA advisory committee tomorrow. |
The Motley Fool
December 30, 2010
Brian Orelli |
This NICE Deal Could Foreshadow 2011 Value-based pricing is coming. The only way to encourage lower drug costs is to get the end user to pay the cost directly. |
The Motley Fool
September 14, 2010
Luke Timmerman |
Arena Obesity Drug Effective by "Slim Margin"; Shares Tumble The market is reacting negatively to news about the company's weight-loss drug. |
Chemistry World
July 16, 2010
Matt Wilkinson |
Bittersweet victory for GSK's Avandia GlaxoSmithKline has received a muted 'thumbs up' from a US regulatory advisory panel for its much-maligned Type 2 diabetes drug Avandia (rosiglitazone), making it likely the US Food and Drug Administration will allow the UK-based pharma giant to continue selling the drug in the US. |
The Motley Fool
March 31, 2011
Brian Orelli |
Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good. |
Reason
November 2008
Jacob Sullum |
Follow State Law, Go Directly to Jail The Drug Enforcement Administration has raided more than 60 medical marijuana dispensaries in the last two years. Because the deck is stacked against them, dispensary operators facing federal drug charges typically plead guilty. |
The Motley Fool
March 25, 2011
Brian Orelli |
Pfile Pfizer Under "Potential" Researchers reported promising finding from a clinical trial of Pfizer's new drug, CP-870,893, in pancreatic cancer patients in the most recent issue of the journal Science. |
The Motley Fool
January 29, 2010
Brian Orelli |
How to Make Billions of Dollars Without Really Trying Lackluster Alzheimer's drugs have been doing it for years. |
The Motley Fool
April 26, 2011
Brian Orelli |
We Hate Your Drug. And That's a Good Thing. This one's a pain for the clinical trial participants. |
The Motley Fool
June 2, 2011
Luke Timmerman |
Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend Infinity Pharmaceuticals' top execs sometimes get strange looks when they say they are developing a new drug for pancreatic cancer. Is this a smart use of the company's time and resources? |
The Motley Fool
June 23, 2010
Kris Eddy |
Drugmakers Finally Recognize the Next Big Opportunity Drug companies seem to be increasing efforts to address female health problems. |
BusinessWeek
January 21, 2010
John Carey |
Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes. |
The Motley Fool
April 16, 2010
Brian Orelli |
It'll Be a Blockbuster! High Fives All Around, Right? Sanofi-aventis releases top-line data for its phase 3 diabetes drug candidate, lixisenatide. The trial was a success, but don't pencil it in as a blockbuster just yet. |
Salon.com
October 12, 2000
Gary Kamiya |
Reefer madness America's surreal hypocrisy about recreational drugs has reached the full-blown Dali stage... |
Reason
January 2006
Jacob Sullum |
That Chemo Cachet Medical marijuana and kids: Hard as it is to believe, it appears that promoting marijuana as a medicine for cancer and AIDS patients does not make it seem cooler to American teenagers. |
The Motley Fool
January 25, 2010
Brian Orelli |
No Way to Hide This Drug Approval FDA trumps Acorda on its good news. The biotech announced Food and Drug Administration approval of Ampyra, its drug to help multiple sclerosis patients walk better after the markets closed on Friday. |
